Nexus AG (LON:0FGL)
70.30
-0.50 (-0.71%)
At close: Jun 13, 2025
Nexus AG Revenue
Nexus AG had revenue of 71.13M EUR in the quarter ending March 31, 2025, with 11.00% growth. This brings the company's revenue in the last twelve months to 272.56M, up 7.58% year-over-year. In the year 2024, Nexus AG had annual revenue of 265.52M with 8.27% growth.
Revenue (ttm)
272.56M EUR
Revenue Growth
+7.58%
P/S Ratio
4.54
Revenue / Employee
142.78K EUR
Employees
1,909
Market Cap
1.04B GBP
Revenue Chart
* This company reports financials in EUR.
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 265.52M | 20.28M | 8.27% |
Dec 31, 2023 | 245.24M | 33.73M | 15.95% |
Dec 31, 2022 | 211.51M | 20.80M | 10.91% |
Dec 31, 2021 | 190.71M | 24.75M | 14.91% |
Dec 31, 2020 | 165.96M | 14.46M | 9.54% |
Dec 31, 2019 | Pro | Pro | Pro |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
AstraZeneca | 42.56B |
GSK plc | 31.53B |
Haleon | 11.23B |
Smith & Nephew | 4.64B |
ConvaTec Group | 1.83B |
Hikma Pharmaceuticals | 2.50B |
HUTCHMED (China) | 503.39M |
Genus | 671.60M |